Dimeric RFX proteins contribute to the activity and lineage specificity of the interleukin-5 receptor α promoter through activation and repression domains

Molecular and Cellular Biology

Volumn 19, Issue 6, 1999, Pages 3940-3950

  Iwama, Atsushi ^b,d   Pan, Jing ^b   Zhang, Pu ^b   Reith, Walter ^c   Mach, Bernard ^c   Tenen, Daniel G ^b   Sun, Zijie ^a,b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

^d KUMAMOTO UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DNA BINDING PROTEIN; INTERLEUKIN 5; INTERLEUKIN 5 RECEPTOR; TRANSCRIPTION FACTOR;

ARTICLE; BINDING SITE; CELL LINEAGE; DELETION MUTANT; DNA BINDING; ENHANCER REGION; EOSINOPHIL; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; PEPTIDE MAPPING; PRIORITY JOURNAL; PROMOTER REGION; RECEPTOR AFFINITY; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION;

EID: 0033049420     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/mcb.19.6.3940     Document Type: Article

References (52)

1. Ayer, D. E., C. D. Laherty, Q. A. Lawrence, A. P. Armstrong, and R. N. Eisenman. 1996. Mad proteins contain a dominant transcription repression domain. Mol. Cell. Biol. 16:5772-5781.
2. Baltus, B., T. B. van Dijk, E. Caldenhoven, E. Zanders, J. A. M. Raaijmakers, J.-W. J. Lammers, L. Koenderman, and R. P. de Groot. 1998. An AP-1 site in the promoter of the human IL-5Rα gene is necessary for promoter activity in eosinophilic HL60 cells. FEBS Lett. 434:251-254.
3. Chen, H. M., P. Zhang, M. T. Voso, S. Hohaus, D. A. Gonzalez, K. G. Christopher, D.-E. Zhang, and D. G. Tenen. 1995. Neutrophils and monocytes express high levels of PU.1 (Spi-1) but not Spi-B. Blood 85:2918-2928.
4. Chirgwin, J. M., A. E. Przybyla, R. J. MacDonald, and W. J. Rutter. 1979. Isolation of biologically active ribonucleic acid from sources rich in ribonuclease. Biochemistry 18:5294-5299.
5. Clausen, B. E., J.-M. Waldburger, F. Schwenk, E. Barras, B. Mach, K. Rajewsky, I. Förster, and W. Reith. 1998. Residual MHC class II expression on mature dendritic cells and activated B cells in RFX5-deficient mice. Immunity 8:143-155.
6. Dignam, J. D., R. M. Lobovitz, and R. G. Roeder. 1983. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11:1475-1489.
7. Emery, P., B. Durand, B. Mach, and W. Reith. 1996. RFX proteins, a novel family of DNA binding proteins conserved in the eukaryotic kingdom. Nucleic Acids Res. 24:803-807.
8. Emery, P., M. Strubin, K. Hofmann, P. Bucher, B. Mach, and W. Reith. 1996. A consensus motif in the RFX DNA binding domain and binding domain mutants with altered specificity. Mol. Cell. Biol. 16:4486-4494.
9. Gleich, G. J., E. A. Ottensen, K. M. Leiferman, and S. J. Ackerman. 1989. Eosinophils and human disease. Int. Arch. Allergy Appl. Immunol. 88:59-62.
10. Hariharan, N., D. E. Kelley, and R. P. Perry. 1989. Equipotent mouse ribosomal protein promoters have a similar architecture that includes internal sequence elements. Genes Dev. 3:1789-1800.
11. Jandl, J. H. 1996. Granulocytes, p. 615-649. In J. H. Jandl (ed.), Blood: textbook of hematology, 2nd ed. Little, Brown and Company, Boston, Mass.
12. Kitamura, T., T. Tange, T. Terasawa, S. Chiba, T. Kuwaki, K. Miyagawa, Y. F. Piao, K. Miyazono, A. Urabe, and F. Takaku. 1989. Establishment and characterization of a human cell line that proliferates dependently on GM-CSF, IL-3, or erythropoietin. J. Cell. Physiol. 140:323-334.
13. + B cells and lack eosinophilia but have normal antibody and cytotoxic T cell responses. Immunity 4:15-24.
14. Lioubin, M. N., P. A. Algate, S. Tsai, K. Carlberg, A. Aebersold, and L. R. Rohrschneider. 1996. p150Ship, a signal transduction molecule with inositol polyphosphate-5-phosphatase activity. Genes Dev. 10:1084-1095.
15. Lopez, A. F., M. F. Shannon, M. M. Chia, L. Park, and M. A. Vadas. 1992. Regulation of human eosinophil production and function by interleukin-5. Immunol. Ser. 57:549-571.
16. Miyajima, A., A. Mui, T. Ogorochi, and K. Sakamaki. 1993. Receptors for granulocyte-macrophage-colony stimulating factor, interleukin-3, and interleukin-5. Blood 82:1960-1974.
17. Muhlethaler-Mottet, A., W. Di Berardino, L. C. Otten, and B. Mach. 1998. Activation of the MHC class II transactivator CIITA by interferon-γ requires cooperative interaction between Stat1 and USF-1. Immunity 8:157-166.
18. Muhlethaler-Mottet, A., L. A. Otten, V. Ateimle, and B. Mach. 1997. Expression of MHC class II molecules in different cellular and functional compartments is controlled by differential usage of multiple promoters of the transactivator CIITA. EMBO J. 16:2851-2860.
19. Müller, C., E. Kowenz-Leutz, S. Grieser-Ade, T. Graf, and A. Leutz. 1995. NF-M (chicken C/EBPβ) induces eosinophilic differentiation and apoptosis in hematopoietic progenitor cells. EMBO J. 14:6127-6135.
20. Nerlov, C., K. M. McNagny, G. Doderlein, E. Kowenz-Leutz, and T. Graf. 1998. Distinct C/EBP functions are required for eosinophil lineage commitment and maturation. Genes Dev. 12:2413-2423.
21. Nordeen, S. K. 1988. Luciferase reporter gene vectors for analysis of promoters and enhancers. BioTechniques 6:454-458.
22. Pahl, H. L., T. C. Burn, and D. G. Tenen. 1991. Optimization of transient transfection into human myeloid cell lines using a luciferase reporter gene. Exp. Hematol. (New York) 19:1038-1041.
23. Paul, C. C., M. Tolbert, S. Mahrer, A. Singh, M. J. Grace, and M. A. Baumann. 1993. Cooperative effects of interleukin-3 (IL-3), IL-5, and granulocyte-macrophage colony-stimulating factor: a new myeloid cell line inducible to eosinophils. Blood 81:1193-1199.
24. Plaut, M., J. H. Pierce, C. J. Watson, J. Hanky-Hyde, R. P. Nordan, and W. E. Paul. 1989. Mast cell lines produce lymphokines in response to cross-linkage of Fc epsilon RI or to calcium ionophores. Nature 339:64-67.
25. Radomska, H. S., C. S. Huettner, P. Zhang, T. Cheng, D. T. Scadden, and D. G. Tenen. 1998. CCAAT/enhancer binding protein α is a regulatory switch sufficient for induction of granulocytic development from bipotential myeloid progenitors. Mol. Cell. Biol. 18:4301-4314.
26. Reinhold, W., L. Emens, A. Itkes, M. Blake, I. Ichinose, and M. Zajac-Kaye. 1995. The Myc intron-binding polypeptide associates with RFX1 in vivo and binds to the major histocompatibility complex class II promoter region, to the hepatitis B virus enhancer, and to regulatory regions of several distinct viral genes. Mol. Cell. Biol. 15:3041-3048.
27. Reith, W., C. Herrero-Sanchez, M. Kobr, P. Silacci, C. Berte, E. Barras, S. Fey, and B. Mach. 1990. MHC class II regulatory factor RFX has a novel DNA-binding domain and a functionally independent dimerization domain. Genes Dev. 4:1528-1540.
28. Reith, W., C. Ucla, E. Barras, A. Gaud, B. Durand, C. Herrero-Sanchez, M. Kobr, and B. Mach. 1994. RFX1, a transactivator of hepatitis B virus enhancer I, belongs to a novel family of homodimeric and heterodimeric DNA-binding proteins. Mol. Cell. Biol. 14:1230-1244.
29. Safrany, G., and R. P. Perry. 1993. Transcription factor RFX1 helps control the promoter of the mouse ribosomal protein-encoding rpL30 by binding to its alpha element. Gene 132:279-283.
30. Sanderson, C. J. 1992. Interleukin-5, eosinophils, and disease. Blood 79: 3101-3109.
31. School, T., S. K. Mahanta, and J. L. Strominger. 1997. Specific complex formation between the type II bare lymphocyte syndrome-associated trans-activators CIITA and RFX5. Proc. Natl. Acad. Sci. USA 94:6330-6334.
32. Shivdasani, R. A., and S. H. Orkin. 1996. The transcriptional control of hematopoiesis. Blood 87:4025-4039.
33. Siegrist, C. A., B. Durand, P. Emery, E. David, P. Hearing, B. Mach, and W. Reith. 1993. RFX1 is identical to enhancer factor C and functions as a transactivator of the hepatitis B virus enhancer. Mol. Cell. Biol. 13:6375-6384.
34. Steimle, V., B. Durand, E. Barras, M. Zufferey, M. R. Hadam, B. Mach, and W. Reith. 1995. A novel DNA-binding regulatory factor is mutated in primary MHC class II deficiency (bare lymphocyte syndrome). Genes Dev. 9:1021-1032.
35. Steimle, V., L. A. Otten, M. Zufferey, and B. Mach. 1993. Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or bare lymphocyte syndrome). Cell 75:135-146.
36. Steimle, V., C.-A. Siegrist, A. Mottet, B. Lisowska-Grospierre, and B. Mach. 1994. Regulation of MHC class II expression by interferon-γ mediated by the transactivator gene CIITA. Science 265:106-109.
37. Sun, Z., D. A. Yergeau, T. Tuypens, J. Tavernier, C. C. Paul, M. A. Baumann, D. G. Tenen, and S. J. Ackerman. 1995. Identification and characterization of a functional promoter region in the human eosinophil IL-5 receptor α subunit gene. J. Biol. Chem. 270:1462-1471.
38. Sun, Z., D. A. Yergeau, I. C. Wong, T. Tuypens, J. Tavernier, C. C. Paul, M. A. Baumann, P. E. Auron, D. G. Tenen, and S. J. Ackerman. 1996. Interleukin-5 receptor α subunit gene regulation in human eosinophil development: identification of a unique cis-element that acts like an enhancer in regulating activity of the IL-5Rα promoter. Curr. Top. Microbiol. Immunol. 211:173-187.
39. Takagi, M., M. Hara, K. Ichihara, K. Takatsu, and A. Mivajima. 1995. Multi-colony stimulating activity of interleukin-5 (IL-5) on hematopoietic progenitors from the transgenic mouse that express IL-5 receptor α subunit constitutively. J. Exp. Med. 181:889-899.
40. Takaki, S., H. Kanazawa, M. Shiiba, and K. Takatsu. 1994. A critical cytoplasmic domain of the interleukin-5 (IL-5) receptor α chain and its function in IL-5-mediated growth signal transduction. Mol. Cell. Biol. 14:7404-7413.
41. Takaki, S., Y. Murata, T. Kitamura, A. Miyajima, A. Tominaga, and K. Takatsu. 1993. Reconstitution of the functional receptors for murine and human interleukin-5. J. Exp. Med. 177:1523-1529.
42. Takatsu, K., A. Tominaga, N. Harada, S. Mita, M. Matsumoto, T. Takahashi, Y. Kikuchi, and N. Yamaguchi. 1988. T-cell replacing factor (TRF)/ interleukin-5 (IL-5): molecular and functional properties. Immunol. Rev. 102:107-135.
43. Tenen, D. G., R. Hromas, J. D. Licht, and D.-E. Zhang. 1997. Transcription factors, normal myeloid development, and leukemia. Blood 90:489-519.
44. Tsai, S., S. Bartelmez, E. Sitnicka, and S. Collins. 1994. Lymphohematopoietic progenitors immortalized by a retroviral vector harboring a dominant-negative retinoic acid receptor can recapitulate lymphoid, myeloid, and erythroid development. Genes Dev. 8:2831-2841.
45. van Dijk, T. B., E. Caldenhoven, J. A. M. Raaijmakers, J.-W. J. Lammers, L. Koenderman, and R. P. de Groot. 1998. The role of transcription factor PU.1 in the activity of the intronic enhancer of the eosinophil-derived neurotoxin (RNS2) gene. Blood 91:2126-2132.
46. Yamaguchi, Y., S. J. Ackerman, N. Minegishi, M. Takiguchi, M. Yamamoto, and T. Suda. 1998. Mechanism of transcription in eosinophils: GATA-1, but not GATA-2, transactivates the promoter of the eosinophil granule major basic protein gene. Blood 91:3447-3458.
47. Yamaguchi, Y., Y. Hayashi, Y. Sugama, Y. Miura, T. Kasahara, S. Kitamura, M. Torisu, S. Mita, A. Tominaga, K. Takatsu, and T. Suda. 1988. Highly purified murine interleukin-5 (IL-5) stimulates eosinophil function and prolongs in vitro survival: IL-5 as an eosinophil chemotactic factor. J. Exp. Med. 167:1737-1742.
48. Yamaguchi, Y., T. Suda, S. Ohta, K. Tominaga, Y. Miura, and T. Kasahara. 1991. Analysis of the survival of mature human eosinophils: interleukin-5 prevents apoptosis in mature human eosinophils. Blood 78:2542-2547.
49. Yoshida, T., K. Ikuta, H. Sugaya, K. Maki, M. Takagi, H. Kanazawa, S. Sunaga, T. Kinashi, K. Yoshimura, J. Miyazaki, S. Takaki, and K. Takatsu. 1996. Defective B-1 cell development and impaired immunity against angiostrongylus cantonensis in IL-5Rα-deficient mice. Immunity 4:483-494.
50. Zhang, D.-E., P. Zhang, N. D. Wang, C. J. Hetherington, G. J. Darlington, and D. G. Tenen. 1997. Absence of granulocyte colony-stimulating factor signaling and neutrophil development in CCAAT enhancer binding protein α-deficient mice. Proc. Natl. Acad. Sci. USA 94:569-574.
51. Ziegler-Heitbrock, H. W., E. Thiel, A. Futterer, V. Herzog, A. Wirtz, and G. Riethmuller. 1988. Establishment of a human cell line (Mono Mac 6) with characteristics of mature monocytes. Int. J. Cancer 41:456-461.
52. Zon, L. I., Y. Yamaguchi, K. Yee, E. A. Albee, A. Kimura, J. C. Bennett, S. H. Orkin, and S. J. Ackerman. 1993. Expression of mRNA for the GATA-binding proteins in human eosinophils and basophils: potential role in gene transcription. Blood 81:3234-3241.